ALANTOS PHARM HOLDING has a total of 49 patent applications. Its first patent ever was published in 2006. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and United States. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are BOUILLOT ANNE MARIE JEANNE, DEVITA ROBERT J and ORIGENIS GMBH.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 12 | |
#2 | EPO (European Patent Office) | 11 | |
#3 | United States | 9 | |
#4 | Canada | 5 | |
#5 | Mexico | 4 | |
#6 | Japan | 3 | |
#7 | Norway | 2 | |
#8 | African Regional Industrial Property Organization | 1 | |
#9 | Israel | 1 | |
#10 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Heterocyclic compounds | |
#3 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Gege Christian | 40 |
#2 | Taveras Arthur | 37 |
#3 | Hochguertel Matthias | 23 |
#4 | Schneider Matthias | 22 |
#5 | Deng Hongbo | 20 |
#6 | Sucholeiki Irving | 20 |
#7 | Steeneck Christoph | 20 |
#8 | Bluhm Harald | 18 |
#9 | Kroth Heiko | 17 |
#10 | Nolte Bert | 16 |
Publication | Filing date | Title |
---|---|---|
WO2009075790A1 | Metalloprotease inhibitors for intra-articular application | |
CA2680173A1 | Metalloprotease inhibitors containing a heterocyclic moiety | |
ZA200710791B | Pyrimidine or triazine fused bicyclic metalloprotease inhibitors | |
EP2099792A1 | Heterotricyclic metalloprotease inhibitors | |
WO2008063671A2 | Heterobicyclic metalloprotease inhibitors | |
AP200704234A0 | Dipeptidyl peptidase-IV inhibitors |